Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease

Aaron B. Waxman,Ricardo Restrepo-Jaramillo,Thenappan Thenappan,Ashwin Ravichandran,Peter J. Engel,Abubakr Bajwa,Roblee P. Allen,Jeremy Feldman,Rahul Argula,Pete Smith,Kristan Rollins,C.Q. Deng,Leigh Peterson,Heidi Bell,Victor F. Tapson,Steven D. Nathan

Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease

2021

Aaron B. Waxman
Ricardo Restrepo-Jaramillo
Thenappan Thenappan
Ashwin Ravichandran
Peter J. Engel
Abubakr Bajwa
Roblee P. Allen
Jeremy Feldman
Rahul Argula
Pete Smith
Kristan Rollins
C.Q. Deng
Leigh Peterson
Heidi Bell
Victor F. Tapson
Steven D. Nathan

Abstract Background No therapies are currently approved for the treatment of pulmonary hypertension in patients with interstitial lung disease. The safety and efficacy of inhaled treprostinil for p...

Keywords:

in patient
Internal medicine
Treprostinil
Interstitial lung disease
Cardiology
Pulmonary hypertension
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations